Recovery Mechanisms of Somatosensory Function in Stroke Patients: Implications of Brain Imaging Studies.
Recovery mechanisms of somatosensory function in stroke patients: implications of brain imaging studies.
Neurosci Bull. 2013 Mar 8;
Jang SH
Somatosensory dysfunction is associated with a high incidence of functional impairment and safety in patients with stroke. With developments… Continue reading
Paroxetine in the Treatment of Dysthymic Disorder Without Co-Morbidities: A Double-Blind, Placebo-Controlled, Flexible-Dose Study.
Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study.
Asian J Psychiatr. 2013 Apr; 6(2): 157-61
Ravindran AV, Cameron C, Bhatla R, Ravindran LN, da Silva TL
Few published studies have evaluated selective serotonin… Continue reading
Alteplase for the Treatment of Catheter Occlusion in Pediatric Patients (March).
Alteplase for the Treatment of Catheter Occlusion in Pediatric Patients (March).
Ann Pharmacother. 2013 Mar 5;
Anderson DM, Pesaturo KA, Casavant J, Ramsey EZ
OBJECTIVE:To review the literature pertaining to the efficacy of alteplase for restoration of patency of… Continue reading
Brain and Mood Changes Over 2 Years in Healthy Controls and Adults With Heart Failure and Ischaemic Heart Disease.
Brain and mood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease.
Eur J Heart Fail. 2013 Mar 4;
Almeida OP, Garrido GJ, Etherton-Beer C, Lautenschlager NT, Arnolda L, Alfonso H, Flicker… Continue reading
Current Evidence for the Clinical Use of Long-Chain Polyunsaturated N-3 Fatty Acids to Prevent Age-Related Cognitive Decline and Alzheimer’s Disease.
Current evidence for the clinical use of long-chain polyunsaturated N-3 Fatty acids to prevent age-related cognitive decline and Alzheimer’s disease.
J Nutr Health Aging. 2013; 17(3): 240-51
Dacks PA, Shineman DW, Fillit HM
An NIH State of the Science… Continue reading